Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Isaac Matthias"'
Publikováno v:
Journal of Medical Case Reports, Vol 11, Iss 1, Pp 1-3 (2017)
Abstract Background Clozapine is known to cause fecal impaction and ileus with resultant colonic necrosis due to compression of colonic mucosa. There are rare reports of clozapine causing necrosis of other portions of the gastrointestinal tract unrel
Externí odkaz:
https://doaj.org/article/96944fe86ea849789c2cd0ba0883ca89
Autor:
Buhagiar, Isaac Matthias, Gatt, Alfred, Papanas, Nikolaos, Scicluna, Andrew, Farrugia, Claudine, Formosa, Cynthia
Publikováno v:
Acta Scientific Orthopaedics. :109-118
Background: Treatment of venous ulcers often includes incorporation of dressings, for reduction of bio-load. Evidence is lacking with regards to which dressing is ideal for healing chronic venous wounds. This study aimed to compare the healing effect
Publikováno v:
Journal of Ultrasound in Medicine
OBJECTIVES B-lines are a lung ultrasound (LUS) artifact that often indicate pathology. Little is known about the optimal ultrasound machine settings to assess B-lines. We compared settings typically used to evaluate B-lines at our institution with ad
Publikováno v:
Journal of Medical Case Reports
Journal of Medical Case Reports, Vol 11, Iss 1, Pp 1-3 (2017)
Journal of Medical Case Reports, Vol 11, Iss 1, Pp 1-3 (2017)
Background Clozapine is known to cause fecal impaction and ileus with resultant colonic necrosis due to compression of colonic mucosa. There are rare reports of clozapine causing necrosis of other portions of the gastrointestinal tract unrelated to c
Autor:
Michael Bonk, Jason Fritz, Jason Lam, Elizabeth Malsin, Mark E. Mikkelsen, Isaac Matthias, Abhishek Bhardwaj, Jacob T. Gutsche
Publikováno v:
Critical Care Medicine. 44:559-559
Autor:
Abhishek Bhardwaj, Isaac Matthias, Jason Lam, Michael Bonk, Elizabeth Malsin, Mark Mikkelsen, Michael Sims, Roy Gay
Publikováno v:
Critical Care Medicine. 44:503-503
Publikováno v:
Blood. 116:4356-4356
Abstract 4356 Introduction: Prognosis of elderly patients (age>60 years) with acute myeloid leukemia (AML) is poor as compared to younger patients with a higher incidence of cardiac co-morbidities. With standard induction therapy, complete remission